1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. CDK
  4. CDK Ligand

CDK Ligand

CDK Ligands (6):

Cat. No. Product Name Effect Purity
  • HY-168440
    Aurora-A ligand 1
    Ligand 98.75%
    Aurora-A ligand 1 is a high-affinity and specific Aurora-A inhibitor with a dissociation constant (Kd) value of 0.85 nM. Aurora-A ligand 1 can serve as a ligand for target protein (Ligands for Target Protein for PROTAC) for the development of PROTAC Aurora-A degraders with antitumor activity. Aurora-A ligand 1 can be used for the synthesis of HLB-0532259 (HY-168439). HLB-0532259 shows anti-tumor activity against neuroblastoma.
  • HY-181275
    CDK9 ligand 4
    Ligand
    CDK9 ligand 4 is a CDK9 ligand. As a ligand for target protein for PROTAC (Ligands for Target Protein for PROTAC), CDK9 ligand 4 serves for the development and design of PROTAC CDK9 degraders, such as PROTAC CDK9 degrader-12 (HY-181231). CDK9 ligand 4 is applicable to the research of HIV-1 infection.
  • HY-181036
    CDK12/13 ligand 3
    Ligand
    CDK12/13 ligand 3 is a CDK12/13 PROTAC ligand. CDK12/13 ligand 3 can be conjugated with E3 ligase ligand (HY-W093272) and linker to synthesize CDK12/13 PROTAC degrader DN1679 (HY-181035). CDK12/13 ligand 3 can be used for cancer research.
  • HY-182810
    CDK9 ligand 5
    Ligand
    CDK9 ligand 5 (Compound 48) is a CDK9 ligand. CDK9 ligand 5 can be used as a ligand for target protein for PROTAC to develop and design degraders of PROTAC CDK9, such as PROTAC CDK9 degrader-9 (HY-168518). CDK9 ligand 5 can be used in cancer research.
  • HY-170979
    CDK9 ligand 3
    Ligand
    CDK9 ligand 3 is the ligand for CDK9 and can be used for synthesis of PROTAC degrader PROTAC CDK9 degrader-11 (HY-170978).
  • HY-183083
    CDK7 ligand 3-CO-C5-COOH
    Ligand
    CDK7 ligand 3-CO-C5-COOH (compound 7) is a conjugate of CDK7 ligand and linker, which can be used for the synthesis of PROTAC TZ1104 (HY-183073).